Publications

  1. I.Skidan, J.Grunwald, R.Thekkedath, A.Degterev, V.Torchilin, A HPLC Method for the Quantitative Determination ofN-{[(2-Hydroxy-5-nitrophenyl)amino]carbonothioyl}-3,5-dimethylbenzamide in Biological Samples, J. Chromatogr., accepted
  2. T.Wang,  N.Kulkarni, G.D’Souza, V.Petrenko, V.Torchilin, On the mechanism of targeting of phage fusion protein-modified nanocarriers: only the binding peptide sequence matters, Mol. Pharm., submitted
  3. McNamara, C., and Degterev, A., Small molecule inhibitors of the PI3-kinase signaling network. Future Med. Chem., 2011, In Press.
  4. Yang W, Ahmed M, Elian M, Hady el-SA, Levchenko TS, Sawant RR, Signoretti S, Collins M, Torchilin VP, Goldberg SN. Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model?Radiology. 2010 Dec;257(3):685-967.
  5. Wei Yang, Muneeb Ahmed, Beenish Tasawwar, Tatynana Levchenko, Rupa R. Sawant, Ayesha Murshid, Stuart K. Calderwood, Vladimir Torchilin,  S. Nahum Goldberg. Heat Shock Protein Antagonist Increase Endpoint Survival of Percutaneous Radiofrequency (RF) Tumor Ablation in a Small Animal Model, In preparation.
  6. Tasawwar B, Ahmed M, Yang W, Levchenko T, Goldberg SN. RF Ablation Therapy: Increases in Drug Accumulation and Tumor Destruction due to Transient Increases in Microvascularity. RSNA 2010, Chicago, IL , Presented Abstract.
  7. Valery A. Petrenko  and Prashanth K. Jayanna, Phage-Mediated Drug Delivery. In: “Phage Nanobiotechnology” (Eds. Valery Petrenko & George Smith), RSC Publishing, Cambridge, UK (2011).
  8. Xu Jing, M. Amiji, “Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor- Targeted Gelatin Nanoparticles”, The 38th Annual Meeting & Exposition of the Controlled Release Society, National Harbor, MD, Jul 2011; Nano Science and Technology Institute (NSTI) Annual Meeting, Boston, MA, Jun 2011; AAPS National Biotechnology Conference, San Francicso, CA, May 2011.
  9. Xu Jing, M. Amiji, “Multimodal Therapeutic Approach for Pancreatic Cancer: Delivery of Combination wt-p53 Gene and Gemcitabine in Epidermal Growth Factor Receptor-Targeted Gelatin Nanoparticles, AAPS Northeast Regional Discussion Group Annual Meeting , Rocky Hill, CT, Apr 2011.
  10. Xu Jing, M. Amiji, “Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-Targeted Gelatin Nanoparticles” Version 2, Northeastern University AAPS Student Chapter Research Showcase, Boston, MA, May 2010;  AAPS Northeast Regional Discussion Group Annual Meeting, Rocky Hill, CT, Apr 2010.
  11. Yang W, Ahmed M, Tasawwar B, Levchenko T, Sawant RR, Collins M, Signoretti S, Torchilin V, Goldberg SN, “Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model”, Minimally Invasive Tumor Therapies Laboratory, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School , Boston, MA , USA, Int J Hyperthermia. 2011;27(6):527-38.
  12. Ahmed M, Moussa M, Goldberg SN: Synergy in cancer treatments between liposomal chemotherapeutics and thermal ablation. Chemistry and Physics of Lipids 2012.
  13. Biswas S, Sawant RR, Dodwadkar NS, Torchilin VP: Liposome Targeting to Mitochondria Using Novel PEG-PE Based Polymer with Terminal Triphenylphosphonium Group. In: 38th Annual Meeting of the Controlled Released Society: August 2011; Baltimore, MD; 2011.
  14. Biswas S, Sawant RR, Dodwadkar NS, Torchilin VP: Reversible Attachment of Specific Ligands to Liposomes: Synthesis and In vitro Characterization. In: 38th Annual Meeting of the Controlled Released Society: August 2011; Baltimore, MD; 2011.
  15. Biswas S, Torchilin VP: Triphenylphosphonium (TPP)-Modified Dendrimer Targets MitochondriaS. 72 Development and Characterization of Micellar Theranostic Agent for Simultaneous Magnetic Resonance Imaging and Cancer Therapy. In: 38th Annual Meeting of the Controlled Released Society: August 2011; Baltimore, MD; 2011.
  16. Ganta S, Singh A, Coleman TP, Williams D, Amiji M: Pharmaceutical nanotechnology: overcoming drug delivery challenges in contemporary medicine. In: Nanomedicine principles and perspectives. Edited by Ge Y, vol. 1 & 2. New York, NY: Springer Publishing; 2012.
  17. Jain S, Attarwala H, Amiji M: Non-condensing polymeric gene delivery systems: principles and application. Nano LIFE (Invited review in the special thematic issue on “Nanomedicine: Therapeutics, Diagnostics, and Imaging” edited by Sofou, S. and Rege, K).
  18. Navarro G, Sawant RR, Biswas S, Essex S, Tros de Ilarduya C, Torchilin VP: P-Glycoprotein Silencing with siRNA delivered by DOPE-modified PEI Overcomes Doxorubicin Resistance in Breast Cancer Cells. In: 38th Annual Meeting of the Controlled Released Society: August 2011; Baltimore, MD; 2011.
  19. Navarro G, Sawant RR, Biswas S, Essex S, Tros de Ilarduya C, Torchilin VP: siRNA Delivered by Phospholipid-Modified PEIs. Implications for Transfection. In: 38th Annual Meeting of the Controlled Released Society: August 2011; Baltimore, MD; 2011.
  20. Navarro G, Sawant RR, Biswas S, Essex S, Tros de Ilarduya C, Torchilin VP: P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells. Nanomedicine 2011.
  21. Sawant RR, Navarro G, Biswas S, Torchilin VP: Polymer-lipid Conjugate: A Versatile Platform for Enhanced Gene Delivery and siRNA-mediated Silencing. In: 38th Annual Meeting of the Controlled Released Society: August 2011; Baltimore, MD; 2011.
  22. Sawant RR, Sriraman SK, Navarro G, Biswas S, Dalvi R, Torchilin VP: Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery. Biomaterials.
  23. Upponi JR, Torchilin VP: Development and Characterization of Micellar Theranostic Agent for Simultaneous Magnetic Resonance Imaging and Cancer Therapy. In: 38th Annual Meeting of the Controlled Released Society: August 2011; Baltimore, MD; 2011.
  24. Xu J, Amiji M: Gene delivery and transfection in human pancreatic cancer cells using epidermal growth factor receptor-targeted gelatin-based engineered nanovectors. Visualized Experiments.
  25. Xu J, Ganesh S, Amiji M: Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery. Int J Pharm 2011.
  26. Yang W, Ahmed M, Tasawwar B, Levchenko T, Sawant RR, Collins M, Signoretti S, Torchilin V, Goldberg SN: Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model. Int J Hyperthermia 2011, 27(6):527-538.
  27. Yang W, Ahmed M, Tasawwar B, Levchenko T, Sawant RR, Torchilin VP, Goldberg SN: Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: Reduced tumor growth and increased animal endpoint survival in a small animal tumor model. Journal of Controlled Release 2012
  • Contact:

    Marina Sheynina
    Phone: 617-373-6004
    Fax: 617-373-7509
    m.sheynina@neu.edu